Coronavirus Treatment Acceleration Program (CTAP) | FDA

Coronavirus Treatment Acceleration Program (CTAP) | FDA

Coronavirus Treatment Acceleration Program (CTAP) CTAP uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful

FDA updated the CTAP webpage with new metrics and FAQs. As of July 31, 2020, 570+ drug development programs are in the planning stages and 270+ trials have been reviewed by FDA.

CTAP page

Related links: An Update and Behind the Scenes: FDA’s Coronavirus Treatment Acceleration Program (July 14, 2020) Coronavirus (COVID-19) | Drugs